EW
RMD icon

Elyxium Wealth’s ResMed RMD Stock Holding History

Elyxium Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-183
Closed -$44.1K – 1031
2025
Q4 		$44.1K Buy
+183
New +$46.8K 0.01% 380

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Elyxium Wealth's RMD Position: Q1 2026 in Review

Elyxium Wealth sold out of ResMed (RMD) in Q1 2026, closing a stake of 183 shares — an estimated $44.1K sold.

Elyxium Wealth first reported a position in RMD in Q4 2025 and held it in 1 quarter. The position peaked at $44.1K in Q4 2025. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Elyxium Wealth reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Elyxium Wealth sold 183 ResMed shares in Q1 2026, an estimated $44.1K.
  • Elyxium Wealth first reported a position in ResMed in Q4 2025 and held it in 1 quarter.
  • Elyxium Wealth's ResMed position peaked at $44.1K in Q4 2025.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.